Changes to Pacira Pharmaceuticals' board
This article was originally published in Scrip
Pacira Pharmaceuticals, a US-based speciality pharma company, has appointed Laura Brege and Paul Hastings to its board. Dr Carl Gordon is stepping down from the board, bringing the total number of board members to eight. Ms Brege serves as executive vice-president of corporate affairs for Onyx Pharmaceuticals, while Mr Hastings is president and CEO of OncoMed Pharmaceuticals.